Sleep Disorders Trial, Recruiting NCT06554496 Sponsor: Nanjing Medical University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06554496
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 80 years of age
  • People who have been diagnosed with Obstructive Sleep Apnea Hypopnea Syndrome (a condition where breathing repeatedly stops or becomes shallow during sleep), with a specific severity score of 5 or more events per hour
  • People who are receiving a first-time diagnosis and have not previously had surgery or used a CPAP breathing machine for sleep apnea
  • People who are willing and able to give written agreement to take part in the study

Who may not be able to join:

  • People with a history of severe stroke or bleeding in the brain, or who have neurological or psychiatric conditions that could affect the study results
  • People with active cancer, severe liver or kidney problems, diabetes, or significant blood vessel diseases
  • People with severe chronic lung disease (COPD), severe asthma, severe high blood pressure in the lungs, or heart failure of any cause
  • People who are pregnant or have any other condition that makes taking part in the study unsuitable (confirm with trial site)
  • People who are considered extremely physically weakened or who have severe underlying health conditions (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanjing Medical University
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
1 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Xanthine Oxidoreductase (XOR) Activity; Apnea-Hypopnea Index (AHI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov